相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis
Ruochen Li et al.
BRITISH JOURNAL OF CANCER (2020)
Poor clinical outcomes of intratumoral dendritic cellespecific intercellular adhesion molecule 3-grabbing non-integrinepositive macrophages associated with immune evasion in gastric cancer
Xin Liu et al.
EUROPEAN JOURNAL OF CANCER (2020)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer
J. T. Wang et al.
ANNALS OF ONCOLOGY (2019)
Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer
Heng Zhang et al.
ANNALS OF SURGERY (2018)
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
Frederick S. Varn et al.
ONCOIMMUNOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation
Matthew F. Krummel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Tumor-infiltrating gamma delta T cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
Jieti Wang et al.
ONCOIMMUNOLOGY (2017)
RORγt and RORα signature genes in human Th17 cells
Glenda Castro et al.
PLOS ONE (2017)
Regulatory T cells that co-express RORt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
Stalin Chellappa et al.
ONCOIMMUNOLOGY (2016)
Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis
Giovanni Almanzar et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection
Heng Zhang et al.
GASTRIC CANCER (2015)
Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis
Kepeng Wang et al.
IMMUNITY (2014)
Treg functional stability and its responsiveness to the microenvironment
Joseph Barbi et al.
IMMUNOLOGICAL REVIEWS (2014)
Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China
Gangshi Wang et al.
PLOS ONE (2013)
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Markus Kleinewietfeld et al.
SEMINARS IN IMMUNOLOGY (2013)
Basic principles of tumor-associated regulatory T cell biology
Peter A. Savage et al.
TRENDS IN IMMUNOLOGY (2013)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw et al.
CLINICAL CANCER RESEARCH (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation
Y Kuniyasu et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
